Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colectomy | 40 | 2024 | 686 | 6.730 |
Why?
|
Fecal Incontinence | 19 | 2023 | 242 | 4.770 |
Why?
|
Colonic Pouches | 14 | 2022 | 122 | 4.140 |
Why?
|
Rectal Neoplasms | 33 | 2024 | 1156 | 4.000 |
Why?
|
Rectal Prolapse | 7 | 2024 | 33 | 3.590 |
Why?
|
Rectum | 18 | 2023 | 891 | 3.240 |
Why?
|
Proctocolectomy, Restorative | 12 | 2022 | 190 | 2.940 |
Why?
|
Diverticulitis | 6 | 2022 | 185 | 2.730 |
Why?
|
Constipation | 10 | 2022 | 564 | 2.560 |
Why?
|
Colitis, Ulcerative | 18 | 2023 | 1920 | 2.500 |
Why?
|
Colonic Neoplasms | 33 | 2022 | 2527 | 2.260 |
Why?
|
Diverticulitis, Colonic | 8 | 2024 | 138 | 2.250 |
Why?
|
Defecation | 12 | 2023 | 190 | 2.230 |
Why?
|
Anal Canal | 13 | 2023 | 374 | 2.130 |
Why?
|
Pelvic Floor | 8 | 2021 | 138 | 1.940 |
Why?
|
Pelvic Organ Prolapse | 4 | 2022 | 112 | 1.580 |
Why?
|
Rectal Diseases | 3 | 2019 | 142 | 1.530 |
Why?
|
Digestive System Surgical Procedures | 8 | 2024 | 571 | 1.460 |
Why?
|
Anastomotic Leak | 6 | 2021 | 163 | 1.370 |
Why?
|
Surgical Wound Infection | 9 | 2022 | 1530 | 1.360 |
Why?
|
Postoperative Complications | 38 | 2023 | 15637 | 1.300 |
Why?
|
Intussusception | 3 | 2019 | 115 | 1.300 |
Why?
|
Irritable Bowel Syndrome | 3 | 2019 | 453 | 1.270 |
Why?
|
Ileostomy | 9 | 2022 | 121 | 1.240 |
Why?
|
Laparoscopy | 16 | 2022 | 2035 | 1.200 |
Why?
|
Colon | 14 | 2023 | 1791 | 1.190 |
Why?
|
Colon, Sigmoid | 4 | 2020 | 124 | 1.180 |
Why?
|
Colorectal Surgery | 7 | 2022 | 122 | 1.120 |
Why?
|
Sigmoid Diseases | 3 | 2013 | 59 | 1.060 |
Why?
|
Quality of Life | 20 | 2024 | 13367 | 1.030 |
Why?
|
Preoperative Care | 4 | 2020 | 2241 | 1.000 |
Why?
|
Consensus | 16 | 2024 | 3134 | 0.980 |
Why?
|
Rectocele | 3 | 2022 | 21 | 0.950 |
Why?
|
Crohn Disease | 7 | 2021 | 2278 | 0.840 |
Why?
|
Colorectal Neoplasms | 15 | 2024 | 6919 | 0.830 |
Why?
|
Ileum | 2 | 2018 | 557 | 0.810 |
Why?
|
Neoplasm Staging | 38 | 2023 | 11119 | 0.770 |
Why?
|
Adenocarcinoma | 13 | 2021 | 6341 | 0.750 |
Why?
|
Perineum | 5 | 2021 | 208 | 0.710 |
Why?
|
Retrospective Studies | 80 | 2024 | 80674 | 0.690 |
Why?
|
Defecography | 6 | 2021 | 17 | 0.640 |
Why?
|
Neoplasm Recurrence, Local | 17 | 2023 | 9278 | 0.600 |
Why?
|
Diagnostic Techniques, Digestive System | 1 | 2018 | 45 | 0.600 |
Why?
|
Ileal Diseases | 1 | 2018 | 68 | 0.590 |
Why?
|
Antibiotic Prophylaxis | 2 | 2020 | 637 | 0.590 |
Why?
|
Middle Aged | 96 | 2024 | 220853 | 0.590 |
Why?
|
Neoadjuvant Therapy | 11 | 2023 | 2827 | 0.580 |
Why?
|
Rectal Fistula | 2 | 2014 | 75 | 0.570 |
Why?
|
Microsurgery | 2 | 2014 | 793 | 0.570 |
Why?
|
Severity of Illness Index | 12 | 2020 | 15841 | 0.560 |
Why?
|
Anastomosis, Surgical | 8 | 2019 | 982 | 0.560 |
Why?
|
Female | 123 | 2024 | 392544 | 0.560 |
Why?
|
Urologic Surgical Procedures | 1 | 2020 | 298 | 0.560 |
Why?
|
Humans | 177 | 2024 | 761208 | 0.560 |
Why?
|
Emergencies | 3 | 2019 | 1217 | 0.550 |
Why?
|
Aged | 84 | 2024 | 169288 | 0.540 |
Why?
|
Ataxia | 3 | 2019 | 305 | 0.540 |
Why?
|
Societies, Medical | 6 | 2021 | 3923 | 0.530 |
Why?
|
Proctoscopy | 2 | 2018 | 40 | 0.530 |
Why?
|
Male | 108 | 2024 | 360693 | 0.530 |
Why?
|
Natural Orifice Endoscopic Surgery | 2 | 2014 | 119 | 0.510 |
Why?
|
Urinary Incontinence | 2 | 2021 | 490 | 0.510 |
Why?
|
Malnutrition | 1 | 2022 | 622 | 0.510 |
Why?
|
Manometry | 6 | 2018 | 453 | 0.500 |
Why?
|
Reoperation | 2 | 2024 | 4303 | 0.490 |
Why?
|
Lymph Nodes | 8 | 2019 | 3461 | 0.480 |
Why?
|
Urology | 1 | 2020 | 400 | 0.480 |
Why?
|
Drug Utilization | 1 | 2020 | 1188 | 0.460 |
Why?
|
Neoplasm Invasiveness | 12 | 2022 | 3590 | 0.450 |
Why?
|
Gynecology | 1 | 2020 | 528 | 0.450 |
Why?
|
Treatment Outcome | 39 | 2024 | 64681 | 0.430 |
Why?
|
Length of Stay | 8 | 2022 | 6417 | 0.420 |
Why?
|
Recurrence | 3 | 2024 | 8457 | 0.410 |
Why?
|
Surgical Wound Dehiscence | 1 | 2014 | 212 | 0.410 |
Why?
|
Logistic Models | 10 | 2020 | 13249 | 0.400 |
Why?
|
Patient Education as Topic | 3 | 2021 | 2317 | 0.400 |
Why?
|
Inflammatory Bowel Diseases | 8 | 2024 | 2421 | 0.390 |
Why?
|
Adult | 58 | 2024 | 221119 | 0.380 |
Why?
|
Anus Neoplasms | 3 | 2020 | 330 | 0.380 |
Why?
|
Medicine | 1 | 2019 | 942 | 0.380 |
Why?
|
Parenteral Nutrition, Total | 1 | 2012 | 304 | 0.380 |
Why?
|
Multivariate Analysis | 13 | 2020 | 12052 | 0.380 |
Why?
|
Reaction Time | 1 | 2018 | 2087 | 0.370 |
Why?
|
United States | 32 | 2024 | 72339 | 0.360 |
Why?
|
Terminology as Topic | 1 | 2018 | 1528 | 0.360 |
Why?
|
Intestine, Small | 1 | 2016 | 1207 | 0.350 |
Why?
|
Survival Rate | 21 | 2021 | 12728 | 0.350 |
Why?
|
Cecum | 1 | 2011 | 233 | 0.350 |
Why?
|
Abdomen | 4 | 2021 | 1128 | 0.350 |
Why?
|
Abdominal Abscess | 2 | 2022 | 153 | 0.340 |
Why?
|
Postoperative Period | 7 | 2024 | 1818 | 0.340 |
Why?
|
Disease-Free Survival | 16 | 2022 | 6819 | 0.340 |
Why?
|
Lymphatic Metastasis | 7 | 2020 | 2913 | 0.330 |
Why?
|
Perioperative Care | 3 | 2017 | 1037 | 0.320 |
Why?
|
Gastrointestinal Agents | 2 | 2014 | 509 | 0.320 |
Why?
|
Radiology | 5 | 2023 | 2112 | 0.320 |
Why?
|
Colostomy | 3 | 2018 | 105 | 0.320 |
Why?
|
Quality Improvement | 6 | 2022 | 3808 | 0.310 |
Why?
|
Lymph Node Excision | 6 | 2021 | 1270 | 0.310 |
Why?
|
Neoplasms, Second Primary | 3 | 2023 | 1052 | 0.310 |
Why?
|
Perioperative Period | 2 | 2020 | 252 | 0.310 |
Why?
|
General Surgery | 2 | 2020 | 1693 | 0.300 |
Why?
|
Follow-Up Studies | 23 | 2021 | 39126 | 0.300 |
Why?
|
Urodynamics | 2 | 2020 | 346 | 0.300 |
Why?
|
Vagina | 1 | 2013 | 841 | 0.290 |
Why?
|
Motor Activity | 1 | 2018 | 2712 | 0.290 |
Why?
|
Databases, Factual | 6 | 2021 | 7966 | 0.290 |
Why?
|
Prospective Studies | 19 | 2024 | 54435 | 0.280 |
Why?
|
Delphi Technique | 4 | 2024 | 848 | 0.280 |
Why?
|
Analgesics, Opioid | 2 | 2020 | 3805 | 0.280 |
Why?
|
Colon, Transverse | 2 | 2018 | 24 | 0.280 |
Why?
|
Aged, 80 and over | 28 | 2021 | 58952 | 0.270 |
Why?
|
Microsatellite Instability | 2 | 2021 | 716 | 0.270 |
Why?
|
Intestinal Diseases | 2 | 2022 | 503 | 0.270 |
Why?
|
Fluoroscopy | 2 | 2021 | 947 | 0.270 |
Why?
|
Enterocolitis, Pseudomembranous | 2 | 2021 | 264 | 0.260 |
Why?
|
Prognosis | 24 | 2022 | 29687 | 0.260 |
Why?
|
Inpatients | 4 | 2023 | 2545 | 0.260 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2005 | 29 | 0.260 |
Why?
|
Cohort Studies | 17 | 2022 | 41496 | 0.250 |
Why?
|
Neoplasm, Residual | 3 | 2021 | 1008 | 0.250 |
Why?
|
Beckwith-Wiedemann Syndrome | 1 | 2005 | 45 | 0.250 |
Why?
|
Patient Selection | 4 | 2020 | 4246 | 0.250 |
Why?
|
Syndrome | 7 | 2022 | 3271 | 0.250 |
Why?
|
Incidence | 13 | 2023 | 21365 | 0.240 |
Why?
|
Antibodies, Monoclonal | 3 | 2014 | 9187 | 0.230 |
Why?
|
Pancreatic Cyst | 1 | 2008 | 367 | 0.230 |
Why?
|
Anti-Bacterial Agents | 2 | 2020 | 7407 | 0.220 |
Why?
|
Colonoscopy | 3 | 2019 | 1395 | 0.220 |
Why?
|
Age Factors | 7 | 2024 | 18384 | 0.220 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7400 | 0.220 |
Why?
|
Carcinoembryonic Antigen | 2 | 2016 | 335 | 0.220 |
Why?
|
Young Adult | 16 | 2021 | 59221 | 0.220 |
Why?
|
Hospices | 2 | 2023 | 245 | 0.210 |
Why?
|
Rest | 1 | 2008 | 920 | 0.210 |
Why?
|
Proportional Hazards Models | 11 | 2022 | 12474 | 0.210 |
Why?
|
Hypoalbuminemia | 1 | 2023 | 86 | 0.200 |
Why?
|
New York | 3 | 2020 | 875 | 0.200 |
Why?
|
Intestinal Perforation | 2 | 2021 | 249 | 0.200 |
Why?
|
Electric Stimulation Therapy | 2 | 2020 | 625 | 0.200 |
Why?
|
Risk Factors | 19 | 2023 | 74239 | 0.200 |
Why?
|
Uterine Prolapse | 1 | 2022 | 68 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 82 | 0.180 |
Why?
|
Phenotype | 1 | 2019 | 16575 | 0.180 |
Why?
|
Chi-Square Distribution | 3 | 2012 | 3418 | 0.180 |
Why?
|
Hospital Records | 1 | 2020 | 93 | 0.180 |
Why?
|
Societies, Scientific | 1 | 2021 | 223 | 0.180 |
Why?
|
Hospitalization | 1 | 2020 | 10707 | 0.180 |
Why?
|
Stress, Psychological | 1 | 2015 | 4487 | 0.170 |
Why?
|
Sigmoid Neoplasms | 2 | 2017 | 53 | 0.170 |
Why?
|
Hospital Mortality | 3 | 2019 | 5295 | 0.170 |
Why?
|
Genital Neoplasms, Male | 1 | 2019 | 68 | 0.160 |
Why?
|
Paget Disease, Extramammary | 1 | 2019 | 51 | 0.160 |
Why?
|
Comorbidity | 8 | 2022 | 10516 | 0.160 |
Why?
|
Registries | 6 | 2024 | 8247 | 0.160 |
Why?
|
Feasibility Studies | 2 | 2024 | 5250 | 0.160 |
Why?
|
Morbidity | 2 | 2022 | 1751 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 8 | 2021 | 36415 | 0.160 |
Why?
|
Abdominal Muscles | 1 | 2019 | 169 | 0.160 |
Why?
|
Time Factors | 10 | 2020 | 39957 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 1 | 2008 | 1812 | 0.160 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2019 | 133 | 0.150 |
Why?
|
Massachusetts | 7 | 2021 | 8837 | 0.150 |
Why?
|
Digital Rectal Examination | 1 | 2018 | 41 | 0.150 |
Why?
|
Pain, Postoperative | 2 | 2019 | 1741 | 0.150 |
Why?
|
Postoperative Care | 2 | 2018 | 1468 | 0.150 |
Why?
|
Cathartics | 1 | 2019 | 126 | 0.150 |
Why?
|
Acute Disease | 2 | 2019 | 7226 | 0.150 |
Why?
|
Adolescent | 11 | 2020 | 88298 | 0.140 |
Why?
|
Early Detection of Cancer | 3 | 2018 | 3198 | 0.140 |
Why?
|
Sutures | 2 | 2021 | 282 | 0.140 |
Why?
|
Early Ambulation | 1 | 2017 | 49 | 0.140 |
Why?
|
Viscera | 1 | 2017 | 138 | 0.140 |
Why?
|
Neoplasm Metastasis | 4 | 2016 | 4909 | 0.140 |
Why?
|
Recovery of Function | 4 | 2021 | 2981 | 0.140 |
Why?
|
Electromyography | 2 | 2013 | 1393 | 0.140 |
Why?
|
Intestinal Obstruction | 1 | 2020 | 432 | 0.140 |
Why?
|
Hospice Care | 1 | 2023 | 678 | 0.140 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2017 | 128 | 0.140 |
Why?
|
Delivery of Health Care | 1 | 2014 | 5333 | 0.130 |
Why?
|
Colitis | 2 | 2023 | 1234 | 0.130 |
Why?
|
Bupivacaine | 1 | 2019 | 411 | 0.130 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2020 | 360 | 0.130 |
Why?
|
Risk Assessment | 10 | 2019 | 24021 | 0.130 |
Why?
|
Health Status Disparities | 2 | 2021 | 1847 | 0.130 |
Why?
|
Survival Analysis | 7 | 2019 | 10088 | 0.130 |
Why?
|
Blood Vessels | 2 | 2019 | 1111 | 0.130 |
Why?
|
Metformin | 1 | 2023 | 910 | 0.130 |
Why?
|
Colon, Descending | 1 | 2015 | 6 | 0.130 |
Why?
|
Colon, Ascending | 1 | 2015 | 14 | 0.130 |
Why?
|
Positron-Emission Tomography | 3 | 2021 | 6585 | 0.130 |
Why?
|
Appendicitis | 1 | 2022 | 676 | 0.120 |
Why?
|
Medical Records | 1 | 2020 | 1409 | 0.120 |
Why?
|
Regression Analysis | 2 | 2015 | 6345 | 0.120 |
Why?
|
Rectovaginal Fistula | 1 | 2014 | 12 | 0.120 |
Why?
|
Predictive Value of Tests | 3 | 2020 | 15308 | 0.120 |
Why?
|
Ostomy | 1 | 2014 | 33 | 0.120 |
Why?
|
Anus Diseases | 1 | 2014 | 54 | 0.120 |
Why?
|
Patient Readmission | 3 | 2020 | 3265 | 0.120 |
Why?
|
Obesity | 3 | 2017 | 12939 | 0.120 |
Why?
|
Genital Neoplasms, Female | 1 | 2019 | 533 | 0.120 |
Why?
|
WT1 Proteins | 1 | 2015 | 184 | 0.120 |
Why?
|
Peritoneum | 1 | 2015 | 225 | 0.120 |
Why?
|
Cytomegalovirus Infections | 1 | 2021 | 828 | 0.120 |
Why?
|
Intestinal Mucosa | 3 | 2019 | 3031 | 0.110 |
Why?
|
Surgical Stapling | 1 | 2014 | 98 | 0.110 |
Why?
|
Gastrointestinal Diseases | 1 | 2022 | 1201 | 0.110 |
Why?
|
Nephrons | 1 | 2015 | 168 | 0.110 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4021 | 0.110 |
Why?
|
Anemia | 1 | 2023 | 1504 | 0.110 |
Why?
|
Salvage Therapy | 1 | 2020 | 1264 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2019 | 970 | 0.110 |
Why?
|
Dextrans | 1 | 2015 | 574 | 0.110 |
Why?
|
Child | 9 | 2020 | 80152 | 0.110 |
Why?
|
Carcinoma in Situ | 1 | 2018 | 791 | 0.110 |
Why?
|
Biofeedback, Psychology | 1 | 2013 | 116 | 0.100 |
Why?
|
Cluster Analysis | 1 | 2020 | 2706 | 0.100 |
Why?
|
Sex Factors | 5 | 2020 | 10553 | 0.100 |
Why?
|
Bariatric Medicine | 1 | 2012 | 12 | 0.100 |
Why?
|
Sexuality | 1 | 2014 | 180 | 0.100 |
Why?
|
Income | 1 | 2021 | 1869 | 0.100 |
Why?
|
Health Expenditures | 2 | 2022 | 2362 | 0.100 |
Why?
|
Erythrocyte Transfusion | 1 | 2017 | 569 | 0.100 |
Why?
|
Tissue Adhesions | 1 | 2013 | 218 | 0.100 |
Why?
|
Hyaluronic Acid | 1 | 2015 | 484 | 0.100 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1746 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2019 | 4309 | 0.100 |
Why?
|
Data Collection | 2 | 2021 | 3320 | 0.100 |
Why?
|
Terminal Care | 1 | 2023 | 1760 | 0.100 |
Why?
|
Reimbursement, Incentive | 1 | 2017 | 542 | 0.100 |
Why?
|
Private Practice | 1 | 2012 | 152 | 0.090 |
Why?
|
Barium Sulfate | 1 | 2011 | 180 | 0.090 |
Why?
|
Enema | 1 | 2011 | 141 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2021 | 3512 | 0.090 |
Why?
|
Pancreatic Neoplasms | 1 | 2008 | 5366 | 0.090 |
Why?
|
Hospitals, University | 1 | 2012 | 565 | 0.090 |
Why?
|
Cadaver | 1 | 2014 | 1358 | 0.090 |
Why?
|
Apgar Score | 1 | 2010 | 126 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2688 | 0.080 |
Why?
|
Dietary Fiber | 1 | 2013 | 758 | 0.080 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8519 | 0.080 |
Why?
|
Sex Distribution | 2 | 2020 | 2277 | 0.080 |
Why?
|
Suture Techniques | 1 | 2014 | 768 | 0.080 |
Why?
|
Physical Examination | 1 | 2015 | 1255 | 0.080 |
Why?
|
Fibroblast Growth Factors | 1 | 2015 | 863 | 0.080 |
Why?
|
Fellowships and Scholarships | 1 | 2017 | 1115 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 4 | 2020 | 6486 | 0.080 |
Why?
|
Linear Models | 1 | 2019 | 5869 | 0.080 |
Why?
|
Glucagonoma | 1 | 2008 | 14 | 0.080 |
Why?
|
Surgical Flaps | 2 | 2014 | 1670 | 0.080 |
Why?
|
Prostheses and Implants | 1 | 2015 | 1273 | 0.080 |
Why?
|
Treatment Failure | 1 | 2014 | 2643 | 0.080 |
Why?
|
Developing Countries | 1 | 2021 | 2863 | 0.080 |
Why?
|
Case-Control Studies | 3 | 2023 | 22174 | 0.080 |
Why?
|
Feces | 1 | 2014 | 1490 | 0.070 |
Why?
|
Sepsis | 2 | 2020 | 2585 | 0.070 |
Why?
|
Hospitals | 2 | 2020 | 3881 | 0.070 |
Why?
|
Hospitals, General | 1 | 2012 | 799 | 0.070 |
Why?
|
Ileus | 2 | 2018 | 66 | 0.070 |
Why?
|
Abscess | 2 | 2022 | 605 | 0.070 |
Why?
|
Contrast Media | 3 | 2021 | 5311 | 0.070 |
Why?
|
Unnecessary Procedures | 1 | 2011 | 418 | 0.070 |
Why?
|
Insulinoma | 1 | 2008 | 121 | 0.070 |
Why?
|
Specialization | 1 | 2012 | 778 | 0.070 |
Why?
|
Patient Care Team | 2 | 2021 | 2515 | 0.070 |
Why?
|
Cause of Death | 3 | 2024 | 3688 | 0.070 |
Why?
|
Telemedicine | 1 | 2024 | 3051 | 0.070 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1869 | 0.070 |
Why?
|
Wound Healing | 2 | 2014 | 2800 | 0.070 |
Why?
|
Evidence-Based Medicine | 2 | 2018 | 3691 | 0.070 |
Why?
|
Sickness Impact Profile | 1 | 2007 | 299 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1923 | 0.060 |
Why?
|
Pelvis | 2 | 2020 | 735 | 0.060 |
Why?
|
Mass Screening | 3 | 2021 | 5426 | 0.060 |
Why?
|
Body Mass Index | 2 | 2014 | 12952 | 0.060 |
Why?
|
ROC Curve | 1 | 2013 | 3584 | 0.060 |
Why?
|
Interdisciplinary Communication | 2 | 2021 | 931 | 0.060 |
Why?
|
Focus Groups | 2 | 2021 | 1413 | 0.060 |
Why?
|
Ultrasonography | 3 | 2023 | 5969 | 0.060 |
Why?
|
Pressure | 1 | 2008 | 1155 | 0.060 |
Why?
|
Adenoma | 1 | 2015 | 2159 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2164 | 0.060 |
Why?
|
Odds Ratio | 2 | 2013 | 9652 | 0.060 |
Why?
|
Nursing Homes | 2 | 2023 | 1083 | 0.060 |
Why?
|
Secondary Prevention | 1 | 2011 | 1472 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2571 | 0.060 |
Why?
|
Swine | 1 | 2014 | 5909 | 0.060 |
Why?
|
Endosonography | 1 | 2008 | 608 | 0.060 |
Why?
|
Medicare | 1 | 2022 | 6773 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2015 | 3446 | 0.050 |
Why?
|
Primary Prevention | 1 | 2011 | 1185 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2019 | 13385 | 0.050 |
Why?
|
Disease Management | 1 | 2013 | 2507 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20588 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2023 | 284 | 0.050 |
Why?
|
Age Distribution | 1 | 2008 | 2871 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6223 | 0.050 |
Why?
|
Hepatectomy | 1 | 2005 | 557 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 9055 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3517 | 0.050 |
Why?
|
Incontinence Pads | 1 | 2021 | 2 | 0.050 |
Why?
|
Probability | 1 | 2007 | 2478 | 0.050 |
Why?
|
Diet | 2 | 2021 | 8048 | 0.050 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 12976 | 0.050 |
Why?
|
Propensity Score | 2 | 2018 | 1916 | 0.050 |
Why?
|
Endoscopy | 1 | 2011 | 1852 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2013 | 4190 | 0.040 |
Why?
|
Lumbosacral Plexus | 1 | 2020 | 54 | 0.040 |
Why?
|
Quebec | 1 | 2020 | 139 | 0.040 |
Why?
|
Intraoperative Care | 2 | 2017 | 767 | 0.040 |
Why?
|
Hematologic Tests | 1 | 2021 | 239 | 0.040 |
Why?
|
Intestinal Fistula | 1 | 2020 | 142 | 0.040 |
Why?
|
Internship and Residency | 2 | 2017 | 5885 | 0.040 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3453 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3354 | 0.040 |
Why?
|
Medical Audit | 1 | 2020 | 452 | 0.040 |
Why?
|
Proctoscopes | 1 | 2018 | 4 | 0.040 |
Why?
|
Surgical Mesh | 1 | 2021 | 311 | 0.040 |
Why?
|
Appendectomy | 1 | 2022 | 434 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2013 | 4320 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 14025 | 0.040 |
Why?
|
Patient Positioning | 1 | 2021 | 326 | 0.040 |
Why?
|
Developed Countries | 1 | 2021 | 448 | 0.040 |
Why?
|
Causality | 1 | 2024 | 1244 | 0.040 |
Why?
|
Standard of Care | 1 | 2021 | 550 | 0.040 |
Why?
|
Marital Status | 1 | 2018 | 425 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3534 | 0.030 |
Why?
|
Epidermis | 1 | 2019 | 526 | 0.030 |
Why?
|
Urinary Catheterization | 1 | 2017 | 193 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11476 | 0.030 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 2632 | 0.030 |
Why?
|
Cytomegalovirus | 1 | 2021 | 750 | 0.030 |
Why?
|
Canada | 1 | 2021 | 2125 | 0.030 |
Why?
|
Liposomes | 1 | 2019 | 783 | 0.030 |
Why?
|
Ablation Techniques | 1 | 2018 | 247 | 0.030 |
Why?
|
Antiemetics | 1 | 2017 | 186 | 0.030 |
Why?
|
Child, Preschool | 2 | 2020 | 42224 | 0.030 |
Why?
|
Travel | 1 | 2021 | 796 | 0.030 |
Why?
|
Morphine | 1 | 2019 | 656 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2020 | 1702 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2022 | 1613 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2019 | 927 | 0.030 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 353 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1321 | 0.030 |
Why?
|
Disease Progression | 2 | 2024 | 13511 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2019 | 1186 | 0.030 |
Why?
|
Ligation | 1 | 2014 | 446 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2015 | 9025 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1453 | 0.030 |
Why?
|
Aftercare | 1 | 2019 | 913 | 0.030 |
Why?
|
GPI-Linked Proteins | 1 | 2015 | 470 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2017 | 578 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1423 | 0.030 |
Why?
|
Program Development | 1 | 2019 | 1294 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2015 | 225 | 0.030 |
Why?
|
Intestines | 1 | 2022 | 1908 | 0.030 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 399 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 793 | 0.030 |
Why?
|
Peripheral Nerves | 1 | 2016 | 479 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1445 | 0.020 |
Why?
|
Signal Transduction | 1 | 2015 | 23416 | 0.020 |
Why?
|
New England | 1 | 2014 | 1052 | 0.020 |
Why?
|
Boston | 2 | 2015 | 9327 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8642 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1936 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2024 | 0.020 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2015 | 668 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1602 | 0.020 |
Why?
|
Age of Onset | 1 | 2017 | 3307 | 0.020 |
Why?
|
Reference Values | 1 | 2017 | 4921 | 0.020 |
Why?
|
Overweight | 1 | 2021 | 2418 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2022 | 3873 | 0.020 |
Why?
|
Enzyme Activation | 1 | 2015 | 3577 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2022 | 11067 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6304 | 0.020 |
Why?
|
Biomedical Research | 1 | 2024 | 3434 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2115 | 0.020 |
Why?
|
Infection Control | 1 | 2015 | 983 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13632 | 0.020 |
Why?
|
Carcinoma | 1 | 2019 | 2330 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 12985 | 0.020 |
Why?
|
Patient Admission | 1 | 2014 | 1365 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1525 | 0.020 |
Why?
|
Genetic Testing | 1 | 2019 | 3537 | 0.020 |
Why?
|
Alcoholism | 1 | 2017 | 1973 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 2455 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14675 | 0.020 |
Why?
|
Blood Loss, Surgical | 1 | 2010 | 637 | 0.020 |
Why?
|
Animals | 2 | 2015 | 168079 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1784 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2017 | 11733 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5425 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2015 | 3596 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5773 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2640 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10218 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9297 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4822 | 0.010 |
Why?
|
Insurance, Health | 1 | 2014 | 2493 | 0.010 |
Why?
|
DNA | 1 | 2015 | 7189 | 0.010 |
Why?
|
Self Report | 1 | 2012 | 3727 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12747 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14392 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10422 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4197 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 30002 | 0.010 |
Why?
|
Blood Pressure | 1 | 2010 | 8479 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 12159 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2010 | 26199 | 0.010 |
Why?
|